PharmaMar employs a comprehensive business model that includes all phases of drug development, from discovery to production to marketing.
 
This process starts with the discovery of new compounds of marine origin that can be used in the treatment of cancer; it continues in the commitment to research and develop these discoveries to deliver effective compounds to the marketplace. This drive to discover novel resources for, and to develop new approaches to, patient care provides PharmaMar with its basis for growth.
 
PharmaMar’s commercial presence in Europe forms an essential part of the company's strategy, and allows licensing the sales rights to our products for the rest of the world. This licensing model includes the co-development of our compounds, for which we seek partners with similar commitment, drive, and vision.